Claudio Scafoglio

• University of California Los Angeles

  Lead investigator

Sources: openalex.org

• Office of the President, University of California

  High Impact Research Project, Pilot trial of SGLT2 inhibitor dapagliflozin for stage Ia lung adenocarcinoma, T35IR9793, 2025–2028, 1 Jul 2025

• Office of the President, University of California

  Pilot trial of SGLT2 inhibitor dapagliflozin for stage Ia lung adenocarcinoma, g9wttj, 2025, 1 Jul 2025

• National Cancer Institute

  R01, Investigating the heterogeneity of glucose transport in lung adenocarcinoma, R01CA237401, 2020–2026, 27 Jan 2025

• Office of the President, University of California

  High Impact Research Project, SGLT2 in early diagnosis and treatment of lung cancer, 26IR-0009H, 2017–2020, 1 Jul 2017

Sources: openalex.org, reporter.nih.gov